European Commission creates scientific committee on pharmaceuticals to address policy/legislative issues.
Executive Summary
EUROPEAN COMMISSION SCIENTIFIC COMMITTEE BEING FORMED TO ADVISE ON LEGISLATION in the European community "concerning medicaments for human and veterinary use," according to a July 24 call for nominations to the committee. Unlike the Committee for Proprietary Medicinal Products and the Committee on Veterinary Medicinal Products under the European Medicines Evaluation Agency, the Scientific Committee on Medicaments and Medical Materials would not routinely review applications for European marketing approval.
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth